CSF2 and multiple sclerosis: GM‐CSF is thought to dysregulate haematopoietic stem cell activity in the context of experimental SpA,57 and the pathogenicity of TH17 cells was dependent on GM‐CSF in a murine model of multiple sclerosis.58